Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2010 TO 2019]"
publishDate:"[2015 TO 2015]"
topic_facet:"Medical Condition: Asymptomatic or mildly symptomatic chemotherapy-naïve bone predominant metastatic castration-resistant prostate cancer MedDRA version: 16.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps);Therapeutic area: Diseases [C] - Cancer [C04]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=publishDate%3A%22%5B2015+TO+2015%5D%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Asymptomatic+or+mildly+symptomatic+chemotherapy-na%C3%AFve+bone+predominant+metastatic+castration-resistant+prostate+cancer+MedDRA+version%3A+16.1Level%3A+PTClassification+code+10036909Term%3A+Prostate+cancer+metastaticSystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=publishDate%3A%22%5B2015+TO+2015%5D%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Asymptomatic+or+mildly+symptomatic+chemotherapy-na%C3%AFve+bone+predominant+metastatic+castration-resistant+prostate+cancer+MedDRA+version%3A+16.1Level%3A+PTClassification+code+10036909Term%3A+Prostate+cancer+metastaticSystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&filter%5B%5D=publishDate%3A%22%5B2015+TO+2015%5D%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Asymptomatic+or+mildly+symptomatic+chemotherapy-na%C3%AFve+bone+predominant+metastatic+castration-resistant+prostate+cancer+MedDRA+version%3A+16.1Level%3A+PTClassification+code+10036909Term%3A+Prostate+cancer+metastaticSystem+Organ+Class%3A+10029104+-+Neoplasms+benign%2C+malignant+and+unspecified+%28incl+cysts+and+polyps%29%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Cancer+%5BC04%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (4)
1
A study investigating the safety of radium-223 dichloride with abiraterone acetate and prednisone/prednisolone given to patients with castration-resistant prostate cancer that has spread to bone, and who never had chemotherapy before. : A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve subjects with bone predominant metastatic castration-resistant prostate cancer (CRPC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2015
Wird geladen...
2
A study investigating the safety of radium-223 dichloride with abiraterone acetate and prednisone/prednisolone given to patients with castration-resistant prostate cancer that has spread to bone, and who never had chemotherapy before. : A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve subjects with bone predominant metastatic castration-resistant prostate cancer (CRPC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2015
Wird geladen...
3
A study investigating the safety of radium-223 dichloride with abiraterone acetate and prednisone/prednisolone given to patients with castration-resistant prostate cancer that has spread to bone, and who never had chemotherapy before. : A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve subjects with bone predominant metastatic castration-resistant prostate cancer (CRPC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2015
Wird geladen...
4
A study investigating the safety of radium-223 dichloride with abiraterone acetate and prednisone/prednisolone given to patients with castration-resistant prostate cancer that has spread to bone, and who never had chemotherapy before. : A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-naïve subjects with bone predominant metastatic castration-resistant prostate cancer (CRPC)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2015
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2010-2019
Filter aufheben
Erscheinungsjahr: 2015-2015
Filter aufheben
Thema: Medical Condition: Asymptomatic or mildly symptomatic chemotherapy-naïve bone predominant metastatic castration-resistant prostate cancer MedDRA version: 16.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps);Therapeutic area: Diseases [C] - Cancer [C04]
Medienart
4
Aufsätze
4
E-Artikel
4
E-Ressourcen
Zeitschriftentitel
4
WHO International Clinical Trials Registry Plat...
Thema
4
610
Medical Condition: Asymptomatic or mildly sympt...
4
Recruitment Status: Authorised-recruitment may ...
4
Study Type: Interventional
Erscheinungszeitraum
2015-2015
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4
Englisch
Haven't found what you're looking for?
Wird geladen...